RESUMEN
Chitosan (CS) is a polymer made up of mainly deacetylated ß-1,4 D-glucosamine units, which is part of a large group of D-glucosamine oligomers known as chitooligosaccharides, which can be obtained from chitin, most abundant natural polymer after cellulose and central component of the shrimp exoskeleton. It is known that it can be used for the development of materials, among which its use stands out in wastewater treatment (removal of metal ions, dyes, and as a membrane in purification processes), food industry (anti-cholesterol and fat, packaging material, preservative, and food additive), agriculture (seed and fertilizer coating, controlled release agrochemicals), pulp and paper industry (surface treatment, adhesive paper), cosmetics (body creams, lotions, etc.), in the engineering of tissues, wound healing, as excipients for drug administration, gels, membranes, nanofibers, beads, microparticles, nanoparticles, scaffolds, sponges, and diverse biological ones, specifically antibacterial and antifungal activities. This article reviews the main contributions published in the last ten years regarding the use and application of CS in medical chemistry. The applications exposed here involve regenerative medicine in the design of bioprocesses and tissue engineering, Pharmaceutical sciences to obtain biomaterials, polymers, biomedicine, and the use of nanomaterials and nanotechnology, toxicology, and Clinical Pharmaceuticals, emphasizing the perspectives and the direction that can take research in this area.
Asunto(s)
Quitosano , Quitosano/química , Quitosano/farmacología , Humanos , Química Farmacéutica , Animales , Ingeniería de Tejidos , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacologíaRESUMEN
The Boltzmann-Gibbs additive entropy SBG=-k∑ipilnpi and associated statistical mechanics were generalized in 1988 into nonadditive entropy Sq=k1-∑ipiqq-1 and nonextensive statistical mechanics, respectively. Since then, a plethora of medical applications have emerged. In the present review, we illustrate them by briefly presenting image and signal processings, tissue radiation responses, and modeling of disease kinetics, such as for the COVID-19 pandemic.
RESUMEN
Wounds result from different causes (e.g., trauma, surgeries, and diabetic ulcers), requiring even extended periods of intensive care for healing, according to the patient's organism and treatment. Currently, wound dressings generated by polymeric fibers at micro and nanometric scales are promising for healing the injured area. They offer great surface area and porosity, mimicking the fibrous extracellular matrix structure, facilitating cell adhesion, migration, and proliferation, and accelerating the wound healing process. Such properties resulted in countless applications of these materials in biomedical and tissue engineering, also as drug delivery systems for bioactive molecules to help tissue regeneration. The techniques used to engineer these fibers include spinning methods (electro-, rotary jet-), airbrushing, and 3D printing. These techniques have important advantages, such as easy-handle procedure and process parameters variability (type of polymer), but encounter some scalability problems. RJS is described as a simple and low-cost technique resulting in high efficiency and yield for fiber production, also capable of bioactive agents' incorporation to improve the healing potential of RJS wound dressings. This review addresses the use of RJS to produce polymeric fibers, describing the concept, type of configuration, comparison to other spinning techniques, most commonly used polymers, and the relevant parameters that influence the manufacture of the fibers, for the ultimate use in the development of wound dressings.
RESUMEN
Silver nanoparticles (AgNPs) have been imposed as an excellent antimicrobial agent being able to combat bacteria in vitro and in vivo causing infections. The antibacterial capacity of AgNPs covers Gram-negative and Gram-positive bacteria, including multidrug resistant strains. AgNPs exhibit multiple and simultaneous mechanisms of action and in combination with antibacterial agents as organic compounds or antibiotics it has shown synergistic effect against pathogens bacteria such as Escherichia coli and Staphylococcus aureus. The characteristics of silver nanoparticles make them suitable for their application in medical and healthcare products where they may treat infections or prevent them efficiently. With the urgent need for new efficient antibacterial agents, this review aims to establish factors affecting antibacterial and cytotoxic effects of silver nanoparticles, as well as to expose the advantages of using AgNPs as new antibacterial agents in combination with antibiotic, which will reduce the dosage needed and prevent secondary effects associated to both.
Asunto(s)
Antibacterianos/uso terapéutico , Nanopartículas del Metal/uso terapéutico , Plata/uso terapéutico , Animales , Antibacterianos/administración & dosificación , Antibacterianos/química , Infecciones Bacterianas/tratamiento farmacológico , Línea Celular , Desarrollo de Medicamentos , Farmacorresistencia Bacteriana , Escherichia coli/efectos de los fármacos , Humanos , Nanopartículas del Metal/administración & dosificación , Nanopartículas del Metal/química , Pruebas de Sensibilidad Microbiana , Nanotecnología , Pseudomonas aeruginosa/efectos de los fármacos , Plata/administración & dosificación , Plata/química , Staphylococcus aureus/efectos de los fármacosRESUMEN
Biocompatible scaffolds are porous matrices that are bone substitutes with great potential in tissue regeneration. For this, these scaffolds need to have bioactivity and biodegradability. From this perspective, 3D printing presents itself as one of the techniques with the greatest potential for scaffold manufacturing with porosity and established structure, based on 3D digital modeling. Thus, the objective of the present work was to produce 3D scaffolds from the poly (lactic acid) (PLA) and the nanostructured hydroxyapatite doped with carbonate ions (CHA). For this purpose, filaments were produced via fusion for the fused-filament 3D printing and used to produce scaffolds with 50% porosity in the cubic shape and 0/90°configuration. The dispersive energy spectroscopy and Fourier transform infrared spectroscopy (FTIR) analysis demonstrated the presence of CHA in the polymeric matrix, confirming the presence and incorporation into the composite. The thermogravimetric analysis made it possible to determine that the filler concentration incorporated in the matrix was very similar to the proposed percentage, indicating that there were no major losses in the process of obtaining the filaments. It can be assumed that the influence of CHA as a filler presents better mechanical properties up to a certain amount. The biological results point to a great potential for the application of PLA/CHA scaffolds in bone tissue engineering with effective cell adhesion, proliferation, biocompatibility, and no cytotoxicity effects.
RESUMEN
Since the discovery of the double helix and the introduction of genetic engineering, the possibility to develop new strategies to manipulate the genome has fascinated scientists around the world. Currently scientists have the knowledge andabilitytoedit the genomes. Several methodologies of gene editing have been established, all of them working like "scissor", creating double strand breaks at specific spots. The introduction of a new technology, which was adapted from the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas bacterial immune system, has revolutionized the genetic therapy field, as it allows a much more precise editing of gene than the previously described tools and, therefore, to prevent and treat disease in humans. This review aims to revisit the genome editing history that led to the rediscovery of the CRISPR/Cas technology and to explore the technical aspects, applications and perspectives of this fascinating, powerful, precise, simpler and cheaper technology in different fields.
Asunto(s)
Sistemas CRISPR-Cas/genética , Edición Génica/métodos , Terapia Genética/métodos , Inmunidad Adaptativa/genética , Animales , Bacterias/genética , Bacterias/inmunología , Sistemas CRISPR-Cas/inmunología , Contención de Riesgos Biológicos , Roturas del ADN de Doble Cadena , Reparación del ADN , Modelos Animales de Enfermedad , Terapia Genética/efectos adversos , Humanos , ARN Guía de Kinetoplastida/genéticaRESUMEN
Some medical applications of magnetic nanoparticles require direct contact with healthy tissues and blood. If nanoparticles are not designed properly, they can cause several problems, such as cytotoxicity or hemolysis. A strategy for improvement the biological proprieties of magnetic nanoparticles is their functionalization with biocompatible polymers and nonionic surfactants. In this study we compared bare magnetite nanoparticles against magnetite nanoparticles coated with a combination of polyethylene glycol 3350 (PEG 3350) and polysorbate 80 (Tween 80). Physical characteristics of nanoparticles were evaluated. A primary culture of sheep adipose mesenchymal stem cells was developed to measure nanoparticle cytotoxicity. A sample of erythrocytes from a healthy donor was used for the hemolysis assay. Results showed the successful obtention of magnetite nanoparticles coated with PEG 3350-Tween 80, with a spherical shape, average size of 119.2 nm and a zeta potential of +5.61 mV. Interaction with mesenchymal stem cells showed a non-cytotoxic propriety at doses lower than 1000 µg/mL. Interaction with erythrocytes showed a non-hemolytic propriety at doses lower than 100 µg/mL. In vitro information obtained from this work concludes that the use of magnetite nanoparticles coated with PEG 3350-Tween 80 is safe for a biological system at low doses.
RESUMEN
Since the discovery of the double helix and the introduction of genetic engineering, the possibility to develop new strategies to manipulate the genome has fascinated scientists around the world. Currently scientists have the knowledge and ability to edit the genomes. Several methodologies of gene editing have been established, all of them working like "scissor", creating double strand breaks at specific spots. The introduction of a new technology, which was adapted from the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas bacterial immune system, has revolutionized the genetic therapy field, as it allows a much more precise editing of gene than the previously described tools and, therefore, to prevent and treat disease in humans. This review aims to revisit the genome editing history that led to the rediscovery of the CRISPR/Cas technology and to explore the technical aspects, applications and perspectives of this fascinating, powerful, precise, simpler and cheaper technology in different fields
RESUMEN
BACKGROUND: A significant number of developing countries have no facilities to produce medical radioisotopes and radiopharmaceuticals. OBJECTIVE: In this paper we show that access to life-saving radioisotopes and radiopharmaceuticals and the geographical distribution of corresponding infrastructure is highly unbalanced worldwide. METHODS: We discuss the main issues which need to be addressed in order to establish the production of radioisotopes and radiopharmaceuticals, which are especially important for developing countries as newcomers in the field. The data was gathered from several sources, including databases maintained by the International Atomic Energy Agency (IAEA), World Health Organization (WHO), and other international organizations; personal interactions with representatives in the nuclear medicine field from different regions of the world; and relevant literature. RESULTS: Developing radioisotope and radiopharmaceutical production program and installing corresponding infrastructure requires significant investments, both man-power and financial. Support already exists to help developing countries establish their medical radioisotope production installations from several organizations, such as IAEA. CONCLUSION: This work clearly shows that access to life-saving radioisotopes and the geographical distribution of corresponding infrastructure is highly unbalanced. Technology transfer is important as it not only immediately benefits patients, but also provides employment, economic activity and general prosperity in the region to where the technology transfer is implemented.
Asunto(s)
Instalaciones Industriales y de Fabricación , Radioisótopos , Radiofármacos , Ciclotrones , Países en Desarrollo , Agencias Internacionales , Medicina Nuclear , Generadores de RadionúclidosRESUMEN
El presente artículo presenta una revisión bibliográfica sobre el diseño de exoesqueletos y las diferentes aplicaciones que estos pueden tener en la vida humana. Se exponen diferentes desarrollos, resaltando las partes más importantes de cada uno y prestando especial atención al área de la ingeniería electrónica presente en estas estructuras. Además, se realiza un agrupamiento de los diseños, dependiendo de la zona corporal para la cual se ha construido el exoesqueleto o de la finalidad del estudio realizado. Finalmente, se presentan desarrollos y estudios que buscan utilizar las señales mioeléctricas como parte fundamental del sistema exoesquelético.
This paper presents a literature review about exoskeletons and their applications in human life. Different developments highlighting the most important parts of each of them, and paying particular attention to the area of electronic engineering related to these structures, are shown. Also, a grouping of the different kinds of structures is made depending on the area of the human body to which the exoskeleton was intended to or depending on the purpose of the research. Finally, various studies and developments which use mioelectric signals as a fundamental part of the system are presented.